Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study

Extended-release osmotic extended-release oral delivery system (OROS) hydromorphone is a strong synthetic opioid designed to maintain a constant blood concentration by once daily dosing. The objective of this observational study was to investigate the clinical usefulness of OROS hydromorphone in pat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Korean Med Sci
Autori principali: Park, Cheol Kyu, Kang, Hyun-Wook, Oh, In-Jae, Kim, Young-Chul, Kim, Yeo-Kyeoung, Na, Kook-Joo, Ahn, Sung-Ja, Kim, Tae Ok, Choi, Young Jin, Song, Geun Am, Lee, Min Ki
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Academy of Medical Sciences 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5102854/
https://ncbi.nlm.nih.gov/pubmed/27822929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2016.31.12.1914
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi